Quantros, Inc.
Links shared publicly online about this topic.
- 1,596total visits
Quantros, Inc.
View full resource at quantros.com
Tags: Hospital, Environment, Hospitals, Litigation
Most Recently Shared on November 17, 2009 at 1:34 pm By:
Carle Foundation Hospital Expands Quantros SRM for a Safer Care Environment and Reduced Litigation Exposure http://bit.ly/3YAlC1
Pretest Surgery App Just DoesnÕt Cut It for Board Prep
imedicalapps.com — “This is an app review for the Pretest Surgery App by Modality, Inc., written by a third-year medical student. This app is available for iPhone, iPod touch, and iPad.” View full resource at imedicalapps.com
Most Recently Shared on May 7, 2012 at 9:00 pm By:
Pretest Surgery App Just Doesn't Cut It for Board Prep http://t.co/LTsn2390
Pfizer Arthritis Pill Raises Safety Concerns, FDA Staff Says - Bloomberg
bloomberg.com — “Pfizer Inc.’s experimental pill to treat rheumatoid arthritis, one of the company’s leading drug candidates, raised “serious safety concerns” in trials, U.S. regulators said today.” View full resource at bloomberg.com
Most Recently Shared on May 7, 2012 at 5:04 pm By:
Dr. Shashank Akerkar Internist, Rheumatologist, Physician, and Doctor
Pfizer's New #Arthritis Pill - Tofacitinib Raises Safety Concerns, FDA Staff Says http://t.co/N0hUg5uO #rheum
iCAD, Breastlink announce agreement to offer Xoft brachytherapy System
news-medical.net — “iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, and Breastlink Medical Group in Southern California, today announced an agreement that will make the Xoft Axxent Electronic Brachytherapy System available to breast cancer patients treated at Breastlink.” View full resource at news-medical.net
Most Recently Shared on May 5, 2012 at 12:37 pm By:
Breast Cancer News: iCAD, Breastlink announce agreement to offer Xoft brachytherapy System: iCAD, Inc., an indus... http://t.co/VkJuheqM
Bringing interactive medical lectures to the iPad: Taimma Communications
imedicalapps.com — “The future of eLearning by Taimma Communications Inc on the iPad. These apps deliver fully narrated learning packages to students.” View full resource at imedicalapps.com
Most Recently Shared on May 4, 2012 at 11:56 pm By:
Bringing interactive medical lectures to the iPad: Taimma Communications http://t.co/n4mBtX8T
AAO
one.aao.org — “AAO” View full resource at one.aao.org
Most Recently Shared on May 4, 2012 at 8:31 pm By:
AAO Medical Society and Ophthalmology
Another site approved for dry AMD stem cell trial [AAO members] http://t.co/HLkz6iHg
How Liquid Crystal Displays Work in an eWriter | Boogie Board | Behind the Scenes | LiveScience
livescience.com — “The Boogie Board eWriter developed by Kent Displays, Inc. as an alternative to paper products.” View full resource at livescience.com
Most Recently Shared on May 4, 2012 at 7:30 pm By:
National Science Fdn Science Enthusiast
The ins and outs of the BoogieBoard eWriter: http://t.co/cBOdHVOA
Drugmakers’ Deal With Obama Said to Be Probed by House - Bloomberg
bloomberg.com — “Pfizer Inc. and Merck & Co. are being pulled into an expanding congressional investigation about the agreement drugmakers reached with the Obama administration to support the Democrats’ overhaul of the U.S. health-care system, according to three people familiar with the talks.” View full resource at bloomberg.com
Most Recently Shared on May 4, 2012 at 4:17 pm By:
Richard G. Lanzara Health Professional
Drugmakers’ Deal With Obama Said to Be Probed by House http://t.co/9u6EeCwT via @BloombergNews #pharma #politics
EndoBarrier Re-Implantation Feasible
medicalnewstoday.com — “According to an announcement made by GI Dynamics Inc., new data results demonstrate that the EndoBarrier®, a new device for the treatment of type 2 diabetes and/or obesity, is feasible and ca” View full resource at medicalnewstoday.com
Most Recently Shared on May 4, 2012 at 4:05 pm By:
EndoBarrier Re-Implantation Feasible: According to an announcement made by GI Dynamics Inc., new data results de... http://t.co/Y8i8YFjI
Preview: U.S. panel seen backing Pfizer's arthritis drug hope - Yahoo! News
news.yahoo.com — “From Yahoo! News: WASHINGTON (Reuters) - Pfizer Inc's experimental rheumatoid arthritis drug goes before an advisory panel next week, a potential blockbuster medicine that would revive faith in the company's research if its benefits are deemed to outweigh its side effects. Most industry analysts expect the Food and Drug Administration's expert committee to recommend approval despite risks posed by higher-than-normal cholesterol and liver enzyme levels and infections for patients taking tofacitin” View full resource at news.yahoo.com
Most Recently Shared on May 4, 2012 at 12:10 pm By:
Arthritis OW OW Health and Active Health Library
Preview: U.S. panel seen backing Pfizer's arthritis drug hope: WASHINGTON (Reuters) - Pfizer Inc's experimental ... http://t.co/EuZGvdyn
Alnylam first quarter revenues decrease to $20.6 million
news-medical.net — “Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today reported its consolidated financial results for the first quarter 2012, and company highlights.” View full resource at news-medical.net
Most Recently Shared on May 4, 2012 at 9:19 am By:
News-Medical.Net Oncology and Health News
Oncology News: Alnylam first quarter revenues decrease to $20.6 million: Alnylam Pharmaceuticals, Inc., a leadin... http://t.co/Brq3qmdV
Acupressure Device Effective In Reducing Postoperative Nausea, Vomiting
medicalnewstoday.com — “In a peer-reviewed published study, a new medically engineered pressure-technology disposable adhesive device (Pressure Right®) developed by Pressure Point Inc. has clinically proven to enhanc” View full resource at medicalnewstoday.com
Most Recently Shared on May 4, 2012 at 8:50 am By:
Drugs and Devices OW OW Health
Acupressure Device Effective In Reducing Postoperative Nausea, Vomiting: In a peer-reviewed published... http://t.co/rZQZ25zX #MedDevice
Affymetrix to acquire eBioscience
news-medical.net — “Affymetrix, Inc., and eBioscience, Inc., a privately-held San Diego, CA-based company with an industry-leading position in flow cytometry and immunoassay reagents for immunology and oncology research and diagnostics, today announced they have amended their existing definitive agreement dated November 29, 2011 under which Affymetrix will acquire eBioscience.” View full resource at news-medical.net
Most Recently Shared on May 4, 2012 at 6:32 am By:
News-Medical.Net Oncology and Health News
Oncology News: Affymetrix to acquire eBioscience: Affymetrix, Inc., and eBioscience, Inc., a privately-held San ... http://t.co/yd1SLA7e
Emergent BioSolutions first quarter total revenues increase to $50.3M
news-medical.net — “Emergent BioSolutions Inc. announced today its financial results for the first quarter ended March 31, 2012.” View full resource at news-medical.net
Most Recently Shared on May 4, 2012 at 6:32 am By:
News-Medical.Net Oncology and Health News
Oncology News: Emergent BioSolutions first quarter total revenues increase to $50.3M: Emergent BioSolutions Inc.... http://t.co/D9Rkx30n
GenVec receives NIAID’s Phase I SBIR grant to support RSV vaccine program
news-medical.net — “GenVec, Inc. announced today that it has received a Phase I Small Business Innovation and Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to support the Company's Respiratory Syncytial Virus (RSV) vaccine program.” View full resource at news-medical.net
Most Recently Shared on May 4, 2012 at 6:13 am By:
GenVec receives NIAID’s Phase I SBIR grant to support RSV vaccine program: GenVec, Inc. announced today that it ... http://t.co/jltN39Bf
Aveo takes 1Q loss as drug development continues - BusinessWeek
businessweek.com — “Aveo Pharmaceuticals Inc. said Thursday it took a loss in the first quarter as it continued development of two experimental cancer drugs.” View full resource at businessweek.com
Most Recently Shared on May 4, 2012 at 5:45 am By:
Drugs and Devices OW OW Health
Aveo takes 1Q loss as drug development continues - BusinessWeek: Updated NewsAveo takes 1Q loss as drug de... http://t.co/NyPVouhZ #drug
Advertisement
